GTBPVSWRBY• 3 Months (Normalized)
GTBP vs WRBY (GT Biopharma Inc. vs Warby Parker Inc.)
Showing Closing Date Range from Jul 2 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1356.57%
GT Biopharma Inc.
Normalized Baseline0.00%
WRBY Performance $27.47
-6.12%
Warby Parker Inc.
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1362.69 pts
GTBP outperforming by 1362.69 percentage points
GTBPWRBY
Spread Trajectory3 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP WRBY
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(61 dates)
| Date | GTBP Price | GTBP Gain (%) | WRBY Price | WRBY Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1356.57% | $27.47 | -6.12% | +1362.69% |
| Sep 28, 2026 | $6.80 | +1340.68% | $24.66 | -15.72% | +1356.40% |
| Sep 25, 2026 | $6.89 | +1359.75% | $26.71 | -8.71% | +1368.46% |
| Sep 24, 2026 | $6.83 | +1347.03% | $26.27 | -10.22% | +1357.25% |
| Sep 23, 2026 | $7.10 | +1404.24% | $23.35 | -20.20% | +1424.44% |
| Sep 21, 2026 | $7.18 | +1421.19% | $23.25 | -20.54% | +1441.73% |
| Sep 18, 2026 | $7.16 | +1416.95% | $22.50 | -23.10% | +1440.05% |
| Sep 17, 2026 | $7.49 | +1486.86% | $24.18 | -17.36% | +1504.22% |
| Sep 16, 2026 | $7.81 | +1554.66% | $23.55 | -19.51% | +1574.17% |
| Sep 15, 2026 | $9.00 | +1806.78% | $24.34 | -16.81% | +1823.59% |
| Sep 14, 2026 | $11.63 | +2363.98% | $25.71 | -12.13% | +2376.11% |
| Sep 11, 2026 | $8.61 | +1724.15% | $24.71 | -15.55% | +1739.70% |
| Sep 10, 2026 | $6.18 | +1209.32% | $24.30 | -16.95% | +1226.27% |
| Sep 09, 2026 | $5.98 | +1166.95% | $24.57 | -16.03% | +1182.98% |
| Sep 08, 2026 | $- | $24.76 | -15.38% | - |
Page 1 of 5